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Psoriasis is a chronic inflammatory disease with a complex genetic architecture. To further advance gene
discovery, we extended our genome-wide association study data set of 1,139 cases and 2,234 controls and
replicated two independent cohorts of 7,200 cases and 10,491 controls. We identified the missense variant
rs2303138 (p.Ala763Thr) within the LNPEP gene associated with psoriasis (Pcombined¼ 1.83 10 13, odds
ratio¼ 1.16) and validated four previously reported genes: IL28RA, NFKBIA, TRAF3IP2, and CARD14 (9.74 10 11
pPp9.37 10 5), which confirmed the involvement of the nuclear factor-kB signaling pathway in psoriasis
pathogenesis. LNPEP, also named insulin-responsive aminopeptidase, was identified as an angiotensin IV receptor.
Protein function prediction suggested that this missense variant of LNPEP was most likely deleterious. Expression
analysis showed that LNPEP was significantly downregulated in psoriatic lesions compared with the control skin
(P¼ 1.44 10 6) and uninvolved patient skin (P¼ 2.95 10 4). Pathway analysis indicated that LNPEPwas involved
in the renin–angiotensin system, which also has a key role in cardiovascular disease and diabetes. These
results provided genetic evidence that psoriasis might share common mechanisms with hypertension and
diabetes, which was consistent with clinical observations. Our study identified a genetic susceptibility factor and
provided genetic evidence of insight into psoriasis pathogenesis with the involvement of the renin–angiotensin
system pathway.
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INTRODUCTION
Psoriasis is a common chronic inflammatory systemic disease
that is characterized by thick, silvery scale patches. It affects
2–5% of Caucasians and 0.1–0.3% of Asians, with varied
disease prevalence and severity across different populations
(Bhalerao and Bowcock, 1998). Psoriasis can be classified into
two types: Type I, with an age of onset of o40 years of age
and positive human leukocyte antigen, and Type II, with an
age of onset of 440 years of age. It has been widely reported
that psoriasis is associated with metabolic syndrome and its
components, such as obesity, diabetes, and hypertension,
which may share similar risk factors, including susceptibility
genes/loci, chronic inflammation, aberrant angiogenesis, and
oxidative stress (Azfar and Gelfand, 2008; Davidovici et al.,
2010). Genome-wide association study (GWAS) have
dramatically changed the landscape of psoriasis genetics.
More than 10 psoriasis GWAS have identified approximately
40 susceptibility loci/genes, including MHC, IL12B, IL23R,
LCE, TNIP1, and TRAF3IP2, which highlights three primary
pathways that have considerable biological relevance
to psoriasis: nuclear factor (NF)-kB–regulated signaling,
mechanisms of T-cell (particularly T helper type 17)
differentiation, and perturbation of the epidermal barrier,
which affects both immune cell activation and keratinocyte
differentiation (Elder, 2009; Ellinghaus et al., 2010; Huffmeier
et al., 2010; Strange et al., 2010; Stuart et al., 2010; Sun et al.,
2010). Recently, a meta-analysis of 3 GWAS identified 15
susceptibility loci, which indicated that innate host defenses
were involved in the development of psoriasis (Tsoi et al.,
2012). However, these genetic factors could not fully explain
genetic susceptibility to psoriasis or a subset of clinical
features, which suggests that additional genetic factors are
yet to be discovered. Motivated by the need for larger data sets
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to improve power to detect more additional risk loci with low
or moderate effect sizes, we extended our initial sample size
to include 1,007 additional healthy controls and performed
two replications in two large independent sample cohorts of
Chinese Han.
RESULTS
Patient population
Psoriasis cases and healthy controls were recruited from multi-
ple hospitals in different regions of China via collaboration. The
clinical diagnoses of all the samples were confirmed by at least
two dermatologists. All controls were clinically assessed as
being without psoriasis, other autoimmune disorders, systemic
disorders, or without a family history of autoimmune disorders
(including first-, second-, and third-degree relatives).
In total, 8,339 patients and 12,725 controls were
included in the final analysis. The analysis was divided into
three stages: the initial stage and Replications 1 and 2. Sample
information for the GWAS and the replication studies are
summarized in Table 1. All of the cases and controls
were matched by gender and age. The mean age of onset
for the psoriasis cases was slightly younger than the mean age
of the controls.
Association results of the GWAS, replications, and combined
samples
To search for additional variants that are associated with
psoriasis, we enlarged our previously reported GWAS sample
from 2,366 individuals to 3,376, including an additional
1,010 controls (see Materials and Methods for the study
description). After removing the outliers (3 controls), a
population structure analysis of the remaining samples
(1,139 cases and 2,234 controls, consisting of our previously
reported initial GWAS samples and an additional 1,007
healthy controls) indicated a minimal overall inflation of
the genome-wide statistical results due to population strati-
fication (lGC¼1.071). In total, 484,884 single-nucleotide
polymorphisms (SNPs) were tested individually for their
association with psoriasis. Notably, a quantile–quantile plot
still showed an excess of significant associations compared
with the expected number of associations. This effect per-
sisted even after removing both the SNPs within the major
histocompatibility complex (MHC) region and the SNPs that
were previously reported to be associated with psoriasis in
the Chinese Han population, which indicates that additional
association signals might exist. After applying a stringent
quality filter, we conducted a genome-wide association
analysis of the 1,139 cases and 2,234 controls. In addition
to the MHC region, we observed a large number of associa-
tion signals with suggestive evidence (Supplementary Figures
S1–S3 online).
Three SNPs showed suggestive association evidence in
Replication 1 with Po0.01: rs2303138 (LNPEP), P¼1.79
 103, odds ratio (OR)¼1.15; rs4672503 (B3GNT2),
P¼2.17104, OR¼ 1.18; and rs2237585 (PON2),
P¼1.15105, OR¼0.76. We genotyped these 3 SNPs in
Replication 2, which consisted of 4,998 cases and 8,285
controls of Chinese Han. The association analysis in Replica-
tion 2 revealed consistent psoriasis association for 2 SNPs
from the initial and Replication 1 stages: rs2303138 (LNPEP),
P¼ 7.77108, OR¼ 1.15, rs4672503 (B3GNT2), P¼
6.24 10 3, OR¼1.07. After performing a heterogeneity
tests using the I2 index (see Materials and Methods), a joint
analysis of the GWAS and the two replication samples showed
genome-wide significance for SNP rs2303138, which was
located within LNPEP at 5q15 (Pcombined¼ 1.83 10 13;
Table 2). The remaining SNP rs4672503 was not significantly
associated with psoriasis in the combined samples and failed
to reach genome-wide significance after heterogeneity test
correction (Table 2). We investigated the association of the
other LNPEP variants in the initial stage and found that
rs2303138 showed the most significant association as a
coding variant in this region (Supplementary Figure S4 online).
Logistic regression analyses conditioned on rs2303138
showed that the associations at the other SNPs disappeared
(the smallest Pcondition¼0.03), indicating that the associations
at significant SNPs were dependent on each other
(Supplementary Figure S5 online).
Replication of European susceptibility loci in the Chinese
population
We investigated six SNPs from six potential loci that were
previously reported to be associated with psoriasis in the
European population in Replication 2 and found signifi-
cant associations for four of those SNPs in the Chinese
Han population (rs4649203, P¼ 9.74 10 11, OR¼1.19;
rs240993, P¼4.18105, OR¼1.11; rs8016947, P¼4.76
 105, OR¼1.11; rs3813063, P¼9.37105,
Table 1. Summary information of the samples for the GWAS and replication studies
Cases Controls
Analysis Sample size Mean age (SD) Mean age of onset (SD) Male/female Sample size Mean age (SD) Male/female
GWAS 1,139 30.98 (12.31) 22.31 (9.59) 669/470 2,234 38.91 (16.01) 1,189/1,045
Replication 1 2,202 35.03 (14.43) 27.26 (13.33) 1,317/885 2,206 29.87 (10.73) 1,193/1,013
Replication 2 4,998 34.74 (14.74) 26.18 (13.54) 2,815/2,183 8,285 29.09 (10.75) 4,194/4,091
Total 8,339 34.31 (14.41) 25.95 (13.10) 4,801/3,538 12,725 30.95 (12.40) 6,576/6,149
Abbreviation: GWAS, genome-wide association study.
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OR¼1.11). Of these SNPs, rs4649203 (IL28RA) surpassed the
genome-wide significance (Po5 108; Table 3).
Genotype–phenotype analysis
Six SNPs that showed consistent nominal association
evidence of Po0.05 in all initial and replication
stages were selected for genotype–phenotype analysis
to explore their relationships with psoriasis subpheno-
types in the Chinese Han population. SNPs rs4649203
and rs2303138 were preferentially associated with
type 1 psoriasis in the combined Chinese Han data
sets (rs4649203, Pheterogeneity¼ 1.91 102, OR¼ 0.87;
rs2303138, Pheterogeneity¼3.91103, OR¼1.15; Supple-
mentary Table S1 online). No nominal heterogeneity was
observed among the ORs for the different subphenotypes
when stratified by family history.
Preliminary functional analysis results for the LNPEP gene
SNP rs2303138 in the coding region of the LNPEP gene leads
to an amino-acid change (A763T), which possibly damages
Table 3. Comparison between association results of six SNPs previously reported in Europeans and our results in
replication study
Our combined results in Chinese Han Previous GWAS in Europeans HapMap
Allele frequencies Allele frequencies Allele frequencies
Chr SNP Gene Allele Cases Controls P OR Cases Controls P OR CEU CHB
1p36.11 rs4649203 IL28RA A 0.6754 0.6362 9.741011 1.19 0.7700 0.7300 6.89 108 1.22 0.7610 0.6310
6q21 rs240993 TRAF3IP2 A 0.5684 0.5426 4.18 10 5 1.11 0.3000 0.2500 5.29 1020 1.36 0.2500 0.5480
14q13.2 rs8016947 NFKBIA C 0.5440 0.5181 4.76 10 5 1.11 0.6100 0.5700 1.52 1011 1.19 0.5350 0.5770
17q11.2 rs4795067 NOS2 G 0.2305 0.2194 3.57 10 2 1.07 0.3970 0.3540 4.00 1011 1.20 0.3230 0.2150
17q25.3 rs3813063 CARD14 C 0.5249 0.4998 9.37 10 5 1.11 0.5300 1 0.5020 1 3.40 108 1 1.11 1 0.4510 0.4740
19p13.2 rs280519 TYK2 A Fail Fail Fail Fail 0.5100 0.4700 4.42 109 1.20 0.4870 0.4370
Abbreviations: CHB, Han Chinese in Beijing; Chr, chromosome; CEU, Utah residents with ancestry from northern and western Europe; GWAS, genome-wide
association study; OR, odds ratio; SNP, single-nucleotide polymorphism.
1Frequency of minor allele and association results from the European population for rs 11652075, which is correlated with rs3813063 in CARD14 region.
Table 2. Association evidence for three SNPs at three loci in GWAS, replication, and combined studies
MAF
P2 OR PHWE
4 I2(%)5
SNP Chr Gene Allele1 Stage Cases Controls
rs4672503 2p15 B3GNT2 T GWAS 0.4289 0.3807 1.31104 1.22 0.82
Replication 1 0.4249 0.3859 2.17104 1.18 1
Replication 2 0.3933 0.3765 6.24103 1.07 0.48
Combined3 0.4065 0.3789 1.18103 1.15 69.69
rs2303138 5q15 LNPEP A GWAS 0.5061 0.4514 2.06105 1.25 0.08
Replication 1 0.5074 0.4736 1.79103 1.15 1
Replication 2 0.4887 0.4547 7.77108 1.15 0.79
Combined3 0.4960 0.4573 1.83 10 13 1.16 8.96
rs2237585 7q21.3 PON2 T GWAS 0.1409 0.1721 9.93104 0.79 0.77
Replication 1 0.1397 0.1752 1.15105 0.76 0.88
Replication 2 0.1567 0.155 7.20101 1.01 0.25
Combined3 0.1502 0.1615 1.26101 0.85 90.64
Abbreviations: Chr, chromosome; GWAS, genome-wide association study; MAF, minor allele frequency; OR, odds ratio; SNP, single-nucleotide
polymorphism.
1Minor allele.
2P-values from the Cochran–Armitage trend test.
3P-values from fixed or random joint analysis (see Materials and Methods).
4PHWE from Hardy–Weinberg equilibrium test in controls of all the three stages.
5I2 used to assessed the extent of heterogeneity.
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the biological function of this gene, as predicted by the
Polyphen webserver (Polyphen score¼ 0.62). The expression
levels in 180 skin biopsies of 58 psoriatic patients and
64 normal healthy controls from GSE13355 in the GEO
database (Nair et al., 2009) showed that LNPEP was
significantly downregulated in the involved skin of psoriasis
patients compared with the skin of the controls
(P¼ 1.44 10 6) and the uninvolved skin of psoriasis
patients (P¼ 2.95 10 4). However, the results showed no
significant differences in expression between the uninvolved
skin from psoriasis patients and the normal skin from the
controls (P¼ 0.586; Supplementary Table S2 online). Pathway
enrichment analysis found that LNPEP is an essential compo-
nent in the renin–angiotensin system, according to the Kyoto
Encyclopedia of Gene and Genomes (KEGG) database
(Supplementary Figure S6 online).
DISCUSSION
Psoriasis is a common, immunologically mediated, inflamma-
tory and hyperproliferative disease of the skin and joints that
is characterized by changes in the amounts of inflammatory
cells and cytokines in the dermis and by altered keratinocyte
differentiation (Bowcock, 2005). Psoriasis and atherosclerosis
have similar histological characteristics, which include T cells,
macrophages, and monocytes. In particular, the extravasation
of T cells through the epithelium is characteristic of both
psoriatic and atherosclerotic plaques (Spah, 2008). Previously,
several psoriasis GWAS with large sample sizes conducted
both in the European and Asian populations identified 460
associated SNPs (Cargill et al., 2007; Liu et al., 2008; Nair
et al., 2009; Zhang et al., 2009b; Ellinghaus et al., 2010;
Huffmeier et al., 2010; Strange et al., 2010; Stuart et al., 2010;
Sun et al., 2010; Tsoi et al., 2012), which implied susceptibility
genes and provided us with many clues regarding disease
pathogenesis in both immune and non-immune pathways.
However, most of the association signals were located in
introns or intergenic regions, which makes their true effect in
the pathogenesis of psoriasis unclear and difficult to detect.
We previously conducted a series of psoriasis GWAS,
including an international collaborative study that identified
and confirmed several immunity-associated genes that were
implicated as biological pathway involved in the pathogenesis
of psoriasis, including the NF-kB signaling (TNIP1, TNFAIP3)
and interleukin-23 signaling (IL23R, IL12B) pathways. How-
ever, many additional interesting signals remain to be con-
firmed that could be linked with previously reported psoriasis
loci to provide clues as to how these genes work in a plausible
functional pathway. By increasing the initial GWAS stage by
1,007 control samples and including a larger replication
sample size, this study enabled us to identify a coding variant
(rs2303138, Pcombined¼ 1.83 10 13) within LNPEP. This
coding variant of LNPEP leads to a missense variant, changing
an alanine residue to a threonine (A763T) in this protein. This
alteration is predicted by Polyphen to possibly result in
damage to the biological function of this gene.
LNPEP, also named insulin-responsive aminopeptidase, was
identified as an angiotensin IV receptor (Albiston et al., 2001).
As far as we are aware, the protein domain of LNPEP where
p.Ala749Thr is located is not characterized, as evidenced
using SMART (http://smart.embl.de/) and InterPro (http://
www.ebi.ac.uk/interpro/). The expression analysis of LNPEP
in skin biopsies (Nair et al., 2009) showed that LNPEP was
significantly downregulated in the involved skin of psoriasis
patients compared with the skin of the controls
(P¼ 1.44 10 6) and the uninvolved skin of psoriasis
patients (P¼2.95104), which further supports the
hypothesis that LNPEP might be involved in the etiology of
psoriasis. Pathway enrichment analysis showed that LNPEP
was a crucial component in the renin–angiotensin system
pathway based on the KEGG database. Interestingly, the
angiotensin-converting enzyme gene, which is also a key
component in the renin–angiotensin system, was widely
reported to be associated with psoriasis (Weger et al., 2007;
Veletza et al., 2008; Lamba et al., 2011) and lends further
support to involvement of the renin–angiotensin system in the
development of psoriasis. Moreover, LNPEP has also been
implicated in diabetes, as it affects glucose uptake via the
interaction of insulin receptor signaling with the insulin-
responsive glucose transporter GLUT4 (Shibata et al., 2007).
It was reported that genetic variants in LNPEP were associated
with biological effects on vasopressin clearance and serum
sodium regulation (Nakada et al., 2011), which are generally
accepted as key biological factors in hypertension, diabetes,
and other metabolic phenotypes (Enhorning et al., 2009; Patel
and Mehta, 2012). Therefore, it is reasonable to speculate that
LNPEP may have a role in the pathogenesis of both psoriasis
and metabolic phenotypes, such as hypertension and diabetes.
Also, patients with psoriasis are at higher risk of developing
systemic co-morbidities, including cardiovascular disease,
metabolic syndrome, and overt diabetes (Spah, 2008;
Davidovici et al., 2010), providing supportive clinical
evidence for our genetic findings.
Furthermore, LNPEP was reported to activate the NF-kB
pathway, thus increasing proinflammatory genes via Ang IV
(Esteban et al., 2005) and playing an important role in cross-
presentation via the function of peptide trimming interacting
with MHC class I molecules (Saveanu et al., 2009). Therefore,
it is possible that LNPEP A763T might also be involved in the
pathogenesis of psoriasis by reducing the availability of
peptides that are presented by the MHC to cytotoxic T
lymphocytes in the antigen-presentation process (Saveanu
et al., 2009).
In addition, we found that IL28RA, TRAF3IP2, NFKBIA, and
CARD14 were significantly associated with psoriasis in the
Chinese Han population. These genetic findings provided
further evidence that the innate host defense focused on
NF-kB and interferon signaling, including LNPEP, IL28RA,
TRAF3IP2, NFKBIA, CARD14, and TNIP1 validated in our
previous GWAS (Sun et al., 2010), were implicated in
the pathogenesis of psoriasis. Fine mapping, functional
characterization, and meta-analyses in additional psoriasis
cohorts will be required to identify the detailed molecular
roles for genetic variation in these pathways. Notably, the SNP
rs11652075 recently reported in European population (Jordan
et al., 2012; Tsoi et al., 2012) also showed a marginal
significance of P¼0.011 in our initial GWAS of 1,139 cases
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and 2,234 controls. The frequency of cases and controls for
the C allele is 0.5373 and 0.5030, respectively, and the same
trend was observed in both the populations. Intriguingly, our
study also found that LNPEP and IL28RA were preferentially
associated with type I psoriasis in the Chinese Han population
(Pheterogeneity¼3.91103 and Pheterogeneity¼1.91102,
respectively). This observation provides further support for
the involvement of the LNPEP gene in generating antigen
peptides presented by MHC-I molecules, because Type I
psoriasis is an MHC-related phenotype (Henseler and
Christophers, 1985).
In summary, our study identified a susceptibility gene
LNPEP and validated three genes, ie., IL28RA, TRAF3IP2,
and NFKBIA, that were previously reported in Europeans. Our
findings shed light on the pathogenesis of psoriasis by
identifying the involvement of the renin–angiotensin system
pathway and further confirming the NF-kB signaling pathway
in psoriasis, in which the LNPEP gene may have a pleiotropic
role in multiple biological processes. Our results provide a
possible genetic link between the coincidence of psoriasis
with hypertension and diabetes in the clinic and suggest that
the additional genetic factors LNPEP and IL28RA may con-
tribute to complex disease phenotypes. This evidence for the
involvement of LNPEP in antigen presentation might contri-
bute to MHC-associated type I psoriasis. These findings will
provide a solid foundation for directed sequencing, functional,
and translational research into psoriasis.
MATERIALS AND METHODS
Study subjects and sample collection
We collected psoriasis cases and controls through collaborations
with multiple hospitals in China. The case and control characteristics
are summarized in Table 1. To maximize the power of the study,
we included original data from the 1,139 cases and 1,227 controls in
the initial stage (Sun et al., 2010), as well as data from 1,007
newly genotyped controls from the Chinese Han population.
The replication samples consisted of two independent cohorts:
Replication 1 (2,202 psoriasis cases and 2,206 healthy controls)
and Replication 2 (4,998 cases and 8,285 controls) from the Chinese
Han population. The clinical diagnosis of all samples for the initial
stage and two replications were confirmed by at least two
dermatologists. After a full clinical checkup, clinical and additional
demographic information from all the participants were collected
using a previously used structured questionnaire (Zhang et al.,
2009b; Sun et al., 2010). All controls were matched for age,
gender, and geographic region, and they were clinically assessed as
being without psoriasis, other autoimmune disorders, systemic
disorders, or a family history of autoimmune disorders (including
first-, second-, and third-degree relatives). Written informed consent
was obtained from all the participants. Approval for the study
was granted by each institutional ethical committee, and the study
was conducted in accordance with the Declaration of Helsinki
principles.
Genotyping and quality control
Genotyping for the additional 1,010 controls in the initial stage was
performed with Illumina Human 610-Quard BeadChips (Illumina,
San Diego, CA), which were included in our previous GWAS data set
of 1,139 psoriasis cases and 1,227 controls (1,139 cases and 2,237
controls in total) from the State Key Lab Incubation of Dermatology,
Ministry of Science and Technology, Anhui Medical University
(AHMU), Hefei, China. After removing population outliers and
stratification using a principal components analysis (PCA)-based
approach, 1,139 cases and 2,234 controls remained for the gen-
ome-wide association analysis. We excluded SNPs that had a call rate
o98%, deviated from the Hardy–Weinberg equilibrium
(PHWEo0.0001 in controls), or were rare (minor allele frequency
(MAF) o5%). All of the samples in the two independent replications
(including a replication of the previously identified SNPs in
Europeans) were genotyped using the Sequenom MassArray system
(Sequenom, San Diego, CA) in the State Key Lab Incubation of
Dermatology, Ministry of Science and Technology, AHMU. Allele
detection was performed using the MALDI-TOF mass spectroscopy
(San Diego, CA). The mass spectrograms were analyzed using the
MassARRAY TYPER software (Sequenom). All experiments were
performed according to the manufacturers’ protocols. Quality control
was conducted on each data set separately using PLINK 1.07.
According to the quality-control measures, we removed samples
with call rates o90% and SNPs with call rates o95%, MAF (o5%),
or deviation from the Hardy–Weinberg equilibrium proportions
(PHWEo 0.01) in the controls. In total, 2,202 cases, 2,206 controls,
and 37 SNPs were available for Replication 1, and 4,998 cases, 8,285
controls, and 8 SNPs were available for Replication 2.
SNP selection for replication
To maximize the detection power for more underlying disease-
associated regions in the initial stage, we chose all top SNPs with
a nominal association of Po1 10 3, after removing all SNPs with
a MAFo0.05 in both the cases and controls, with Hardy–Weinberg
equilibrium test P-values o0.01 in the controls, or that were
genotyped for replication in our previous study. In total, 41 SNPs
were selected for Replication 1 (Supplementary Table S3 online).
Six SNPs that were selected from among the previously identified
loci in the European population and were reported in more than one
study or within biological candidate genes were investigated in
Replication 2 (Huffmeier et al., 2010; Strange et al., 2010; Stuart
et al., 2010; Jordan et al., 2012; Tsoi et al., 2012).
Statistical analysis
After incorporating 1,007 additional healthy controls into the previous
GWAS data and stringent quality filtering, we conducted the
quantile–quantile plot and genomic control using the statistical
analysis program R (see URLs) to evaluate the overall significance
of the genome-wide association results and the potential impact of
population stratification. Then PCA was applied to the remaining
SNPs using EIGENSTRAT (Patterson et al., 2006; Price et al., 2006) for
two steps. Firstly, the 206 reference samples from the International
HapMap Project: 57 Yoruba samples from Ibadan, Nigeria (YRI); 44
Japanese samples from Tokyo, Japan; 45 Han Chinese samples from
Beijing, China (CHB); and 60 CEPH (Utah residents with ancestry
from northern and western Europe) samples (CEU) were included in
our GWAS data for a PCA. After removal of outliers, the remaining
samples in our initial stage were analyzed similarly by PCA
implemented in EIGENSTRAT. Finally, the genotyping data for
484,884 SNPs were analyzed in 1,139 cases and 2,234 controls in
our initial stage.
H Cheng et al.
A Follow-Up Study of GWAS for Psoriasis
www.jidonline.org 363
SNP association with psoriasis in the initial, two replication stages
(Replications 1 and 2, including validation of European susceptibility
genes/loci) was analyzed using the Cochran–Armitage trend test
implemented in PLINK1.07. After performing heterogeneity test
(I2 and P-values of the Q statistics) between the three cohorts using
the method described previously (Higgins and Thompson, 2002), we
conducted a joint association analysis of the combined data on the
initial and two replication stages. Two approaches were adopted
in our combined analysis described elsewhere (Sun et al., 2010):
If I2 was o30%, the fixed effect model (Mantel–Haenszel) was
used(Mantel and Haenszel, 1959) and otherwise the random effect
model (DerSimonian–Laird) was implemented (DerSimonian and
Laird, 1986).
In subphenotype analysis, the logistic regression analysis
restricted to cases (case-only analyses) was performed with sub-
clinical phenotypes as the outcome variable (Zhang et al., 2009a;
Sun et al., 2010).
Preliminary functional analysis of LNPEP
The possible impact of an amino-acid substitution on protein structure
and function was predicted by PolyPhen (Adzhubei et al., 2010).
The expression levels of the susceptible gene in 180 skin tissues were
obtained from GSE13355 in the GEO database, which consisted of
one biopsy of the normal skin from 64 control individuals and two
biopsies (one of the involved skin, one of the uninvolved skin)
from 58 psoriatic subjects (Nair et al., 2009). Gene expression was
contrasted among different groups of samples using the two sample
t-tests for comparisons that involved three groups: psoriatic skin from
cases and healthy skin from controls, involved and uninvolved
skin from affected individuals, and uninvolved skin from cases and
normal skin from controls. Samples were run on Affymetrix U133
Plus 2.0 arrays (Santa Clara, CA) to evaluate the expression of
B54,000 probes following the manufacturer’s protocol (Nair et al.,
2009). Pathway maps from the KEGG (Kanehisa and Goto, 2000),
using both DAVID bioinformatics resources (DAVID) (Huang da
et al., 2009a, b) and the KOBAS 2.0 server (KOBAS) (Xie et al.,
2011), were constructed to show the detailed biological processes of
the LNPEP gene in the pathways.
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